相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antigen-specific therapeutic approaches for autoimmunity
Pau Serra et al.
NATURE BIOTECHNOLOGY (2019)
The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management
Reza Yazdani et al.
CLINICAL IMMUNOLOGY (2019)
GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells
Masaaki Hotta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Multiple sclerosis - a review
R. Dobson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4+ CD25high FOXP3+ Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor Recognition
Cody D. Moorman et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
Suzi B. Claflin et al.
FRONTIERS IN NEUROLOGY (2019)
Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS)
Simon Glatigny et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Regulatory T cells in multiple sclerosis and myasthenia gravis
K. M. Danikowski et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation
Andrew Jones et al.
FRONTIERS IN IMMUNOLOGY (2017)
Partial CD25 Antagonism Enables Dominance of Antigen-inducible CD25high FOXP3+ Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive Immunotherapy
Daniel S. Wilkinson et al.
FRONTIERS IN IMMUNOLOGY (2017)
The CD40-CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Suzanne A. B. M. Aarts et al.
FRONTIERS IN IMMUNOLOGY (2017)
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study
Paolo Ragonese et al.
BMC NEUROLOGY (2017)
Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4+ Tcells specific for both a myelin and a neuronal self-antigen in mice
Liliana E. Lucca et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice
Debjani Ghosh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+T lymphocytes as pathogenic effectors and therapeutic targets
Reinhard Hohlfeld et al.
LANCET NEUROLOGY (2016)
Infection Risk in Patients on Multiple Sclerosis Therapeutics
Eric M. Williamson et al.
CNS DRUGS (2015)
Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy
Shirin Karimi et al.
IMMUNOLOGY (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
GM-CSF-Neuroantigen Fusion Proteins Reverse Experimental Autoimmune Encephalomyelitis and Mediate Tolerogenic Activity in Adjuvant-Primed Environments: Association with Inflammation-Dependent, Inhibitory Antigen Presentation
S. M. Touhidul Islam et al.
JOURNAL OF IMMUNOLOGY (2014)
Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS
Michail Koutrolos et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
FOXP3 and scurfy: how it all began
Fred Ramsdell et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Regulatory T cells: recommendations to simplify the nomenclature
Abul K. Abbas et al.
NATURE IMMUNOLOGY (2013)
Tolerogenic vaccines for Multiple Sclerosis
Mark D. Mannie et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Immune modulating peptides for the treatment and suppression of multiple sclerosis
Ahmed H. Badawi et al.
CLINICAL IMMUNOLOGY (2012)
Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis
Mark D. Mannie et al.
FRONTIERS IN IMMUNOLOGY (2012)
Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE)
Derek J. Abbott et al.
BMC IMMUNOLOGY (2011)
Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant
Na Li et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2011)
A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC
J. Lori Blanchfield et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+regulatory T cell function
Donald Cheatem et al.
CLINICAL IMMUNOLOGY (2009)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
GM-CSF-induced CD11c+CD8a-025EFdendritic cells facilitate Foxp3+and IL-10+regulatory T cell expansion resulting in suppression of autoimmune thyroiditis
Balaji B. Ganesh et al.
INTERNATIONAL IMMUNOLOGY (2009)
Depletion of CD4+ CD25+ T Cells Exacerbates Experimental Autoimmune Encephalomyelitis Induce by Mouse, but Not Rat, Antigens
Eitan M. Akirav et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis
Gurumoorthy Krishnamoorthy et al.
NATURE MEDICINE (2009)
The evolutionary conundrum of pathogen mimicry
Nels C. Elde et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associatd with an expansion of FoxP3+, regulatory T cells
Jian Rong Sheng et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-4 responsive CD4+ T cells specific for myelin basic protein:: IL-2 confers a prolonged postactivation refractory phase
MD Mannie et al.
IMMUNOLOGY AND CELL BIOLOGY (2003)
GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis
H Lu et al.
JOURNAL OF IMMUNOLOGY (2002)
CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation
AM Girvin et al.
JOURNAL OF AUTOIMMUNITY (2002)
分享论文
